Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Mitsubishi takes stake in RRJ-backed Fullerton Health to fuel Southeast Asia growth
Mitsubishi takes stake in RRJ-backed Fullerton Health to fuel Southeast Asia growth Mitsubishi Corp. has acquired a minority stake in Singapore-based Fullerton Health, joining private equity backer RRJ Capital in supporting the company’s next phase of growth,...
Lyric Capital leads $1bn financing talks backed by The Weeknd’s music rights
Lyric Capital leads $1bn financing talks backed by The Weeknd’s music rights The Weeknd is in advanced discussions to raise about $1bn in financing backed by his music rights, in a potential landmark deal for the fast-growing music royalties market, according to...
Advent buys PatientPoint from L Catterton and Littlejohn to drive growth in digital health
Advent buys PatientPoint from L Catterton and Littlejohn to drive growth in digital health Advent International has agreed to acquire PatientPoint, the largest digital point-of-care engagement network in the United States, from a shareholder group led by L Catterton...